✦ LIBER ✦

Estramustine in combination with vinblastine and mitomycin-C for patients with progressive androgen independent adenocarcinoma of the prostate

✍ Scribed by Amato, R J; Bui, C; Logothetis, C J

Book ID: 110073108
Publisher: Nature Publishing Group
Year: 1999
Tongue: English
Weight: 77 KB
Volume: 2
Category: Article
ISSN: 1365-7852
DOI: 10.1038/sj.pcan.4500299

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Estramustine and vinblastine for patient

Estramustine and vinblastine for patients with progressive androgen-independent adenocarcinoma of the prostate

✍ Robert J. Amato; Julie Ellerhorst; Cu Bui; Christopher J. Logothetis 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 621 KB

868 A tolerance and efficacy study of th

868 A tolerance and efficacy study of thalidomide, paclitaxel, estramustine combination for patients with chemotherapy refractory androgen independent prostate carcinoma

✍ D. Daliani; P. Dieringer; P. Matthew; L. Pagliaro; K. Davies; N. Tannir; I. Chen 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 168 KB

The pattern of serum markers in patients

The pattern of serum markers in patients with androgen-independent adenocarcinoma of the prostate

✍ Jeri Kim; J.Lynn Palmer; Laury Finn; Sherie Hodges; Victoria Bowes; Leonard Deft 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Low Dose Ketoconazole With Replacement D

Low Dose Ketoconazole With Replacement Doses of Hydrocortisone in Patients With Progressive Androgen Independent Prostate Cancer

✍ Harris, Katherine A.; Weinberg, Vivian; Bok, Robert A.; Kakefuda, Mika; Small, E 📂 Article 📅 2002 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 65 KB

Multicenter Phase II study of estramusti

Multicenter Phase II study of estramustine phosphate plus weekly paclitaxel in patients with androgen-independent prostate carcinoma

✍ David J. Vaughn; Archie W. Brown Jr.; W. Graydon Harker; Sang Huh; Lance Miller; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 2 views

## Abstract ## BACKGROUND The current study determined the efficacy and toxicity of weekly paclitaxel in combination with estramustine phosphate (EMP) in patients with androgen‐independent prostate carcinoma (AIPC). ## METHODS Patients with progressive AIPC received 90 mg/m^2^ paclitaxel by 1‐ho

Dose escalation of oral vinorelbine in c

Dose escalation of oral vinorelbine in combination with estramustine in hormone-refractory adenocarcinoma of the prostate

✍ Niklas J. Mackler; Rodney L. Dunn; Beth Hellerstedt; Kathleen A. Cooney; Judith 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB